Choose Language: Thai | English
Company Background

Bangkok Dusit Medical Services Public Company Limited was established on 30th October 1969 under the name "Bangkok Dusit Medical Services Company Limited" with initial registered capital of Baht 10 million. On 26th February 1972, Bangkok Hospital commenced operations in providing medical services. Through business expansion, the Company was listed on the Stock Exchange of Thailand on 2nd October 1991 and registered its conversion to public company limited in 1994. As of October 2013 has a registered capital of Baht 1,700.00 million, with paid-up capital of Baht 1,549.09 million.

Significant events in the past years


The Company invested in Krungthon Hospital Public Company Limited "KDH", a company listed on the Stock Exchange of Thailand and operating a 150-bed private hospital, by acquiring shares from existing shareholders of KDH with initial investment equal to 16.82% of registered and paid-up capital of KDH. Later, the Company acquired additional shares through the Stock Exchange of Thailand, resulting in total number of shares held equal to 20.01% of registered and paid-up capital of KDH.

The Company increased capital in Greenline Synergy Company Limited, a subsidiary in which the Company holds 100%, from Baht 30 million to Baht 200 million in order to improve information technology services provided to the Group.

Wattanosoth Hospital, the cancer hospital, opened the Bangkok Hematology Center on 20th August 2010 to provide medical care to patients with blood disease by a team of hematology physicians and diagnosis laboratory which meets high standards, as well as a blood bank to store and reserve blood. The Bangkok Hematology Center provides efficient holistic medical care to patients with blood disease.

The Company went through some restructuring. On 28th October 2010, the Company executed an Entire Business Transfer of Bangkok Hospital Hua Hin Company Limited, a subsidiary in which the Company holds 100% and was established as a 60-bed private hospital in Hua Hin, Prachuabkirikhan Province. The purpose of the Entire Business Transfer was to transfer operations of the Bangkok Hospital Hua Hin from the subsidiary to Bangkok Dusit Medical Services Public Company Limited, as a branch of Bangkok Hospital in Hua Hin, in order to reduce management costs and increase flexibility in management of operations and resources, especially in management of medical personnel, which will increase operational efficiency to meet the Company's policy.
The Bangkok Hospital Hua Hin is an investment project which received support from the Board of Investment. The investment capital is approximately Baht 850 million. On the day of the entire business transfer, Bangkok Hospital Hua Hin was still under construction and not yet in operation. After the transfer of the business and all assets to the parent company, the Bangkok Hospital Hua Hin Company Limited registered the closing of the business on 5th November 2010 and is currently in the liquidation process.

The Company increased capital in Royal Bangkok Healthcare Company Limited, a subsidiary in which the Company holds 100%, from initial registered capital of Baht 1.0 million to Baht 736.0 million. The increased capital was used to acquire all shares of A.N.B. Laboratories Company Limited ("ANB") from existing shareholders on 1st December 2010 with total investment of Baht 734.0 million. ANB is the 4th largest producer of saline in the country. In addition, the company also produces and distributes medicine and medical supplies with exports equaling about 20% of total sales.

The Board of Directors' special agenda meeting 2/2010 on 14th December 2010 approved the merger of the Company and Health Network Public Company Limited (Phyathai Hospital Group and Paolo Hospital Group) through an Entire Business Transfer of Health Network Public Company Limited, which is majority held by Mr. Wichai Tongtang and family. The Company shall pay a total of no more than Baht 9,825,357,789 for the merger, comprised of newly issued common shares of the Company in the amount of no more than 230,870,405 shares at Baht 37.75 per share, equal to no more than Baht 8,715,357,789 and cash of approximately Baht 680,000,000, as well as transfer of load debt and interest incurred from Health Network in the amount of no more than Baht 430,000,000.

The Company invested in an Open MRI 1.0 T, the only such machine in Thailand. Patients do not need to enter the tunnel when getting a scan as before, which greatly reduces patient's anxiety of confined spaces and does not require anesthesia.

The Bangkok Spine Academy has performed minimal invasive spine surgery using a microscope to reduce pain and blood loss and for faster recuperation.

The Bangkok Heart Hospital and the Pacific Rim Electrophysiology Research Institute established the "Pacific Rim Electrophysiology Research Institute at Bangkok Hospital" and the "Cardiac Electrophysiology Clinic" headed by Dr. Koonlawee Nademanee, an American Board cardiologist specializing in cardiac electrophysiology. The Institute provides diagnosis and treatment of a variety of irregular heart rhythms (cardiac arrhythmias) using catheter ablation, electrophysiology and cardiac device implantation.

The Company invested in the Bi-plane DSA used in diagnosis and treatment of strokes and other blood vessels with visual effects using 2 megapixel digital imaging. The technology enables doctors to more efficiently diagnose by creating 3 dimension imaging, which can clearly show blood vessels that are as thin as a strand of hair.

In February 2011, the Company invested in 46,116,400 common shares of Bumrungrad Hospital Public Company Limited ("BH"), equal to 6.32% of outstanding shares sold of BH, as well as invested in 35,000,000 units of NVDR or 4.79% of shares outstanding of BH. The Company later exercised the 1:1 conversion of NVDR to common shares, as well as invested in additional common shares of BH. Presently, the Company holds 103,827,600 shares or 14.25% of shares outstanding of Bumrungrad Hospital Public Company Limited.

The Company registered additional capital of Baht 1,481,034,024 on 1st April 2011 to pay for the entire business transfer of Health Network Public Company Limited in accordance with the Extraordinary Meeting of the Shareholders 1/2011 on 24th February 2011. This resulted in the Company holding 68.64% from 19.47% of Prasit Pattana Public Company Limited (Phyathai Hospital Group: Phyathai Hospital 1-3 and Phyathai Hospital Sriracha). In addition, the Company now holds shares of 4 companies within the Paolo Memorial Hospital Group, namely, 100% of Paolo Medic Company Limited (Paolo Memorial Hospital Phaholyotin), 88.73% of Paolo Samutrprakarn Company Limited (Paolo Memorial Hospital Samutrprakarn), 80.72% of Siam Medical Company Limited (Paolo Memorial Hospital Chokchai 4) and 99.76% of Thai Medical Center Public Company Limited (Paolo Memorial Hospital Nawamintr). Consequently, after the mergers, the Company now has 27 hospitals in the Group, from 19 (25 hospitals in Thailand and 2 hospitals in Cambodia), with a total of 4,987 beds, up from 3,193 beds.

The Company made a tender offer on Prasit Pattana Public Company Limited ("PYT") with a period of 25 business days from 8th April to 23rd May 2011. Payment was offered in two ways, namely, Baht 3.71 cash per share or common shares of the Company ("BDMS") at 10.1706 PYT shares for 1 BDMS share. The respondents must choose either option.
After the tender offer, the Company held 97.10% of PYT outstanding shares, up from 68.64%. The Company issued 64,366,277 rights shares to respondents who chose to receive BDMS shares, resulting in Baht 1,545,400,481 of paid-up capital from Baht 1,481,034,024.

The Company increased paid-up capital by another Baht 58,200 to accommodate the conversion of the convertible bonds to common shares of the Company, resulting in a paid-up capital of Baht 1,545,458,883. The convertible bonds matured in July 2011, therefore, the Company no longer has any convertible bond obligations.

The Company invested in an additional 1,474,000 common shares of Udon Pattana (1994) Company Limited (Ake Udon Hospital) equal to 4.9%, resulting in 4,474,000 shares or 14.9% of shares outstanding, up from 3,000,000 shares or 10%. When including ownership of Udon Pattana shares through Prasit Pattana Public Company Limited and Ramkamhaeng Hospital Public Company Limited, a subsidiary and associated company respectively, the Company holds 28.17% of shares outstanding of Ake Udon Hospital.

The Company set up a subsidiary, "Bangkok Premier Life Insurance Broker Company Limited" with registered and paid-up capital of Baht 4.0 million (Baht 10 par value).

The Company invested in an additional 70,522,600 common shares of Bumrungrad Hospital Public Company Limited equal to 9.66% of registered and paid-up capital. Consequently, the Company now holds 174,350,200 shares or 23.88% of registered and paid-up capital of Bumrungrad Hospital Public Company Limited.

The Annual General Meeting of the Shareholders in 2012 approved the decrease of registered capital in the amount of Baht 7,932,525 from Baht 1,553,391,408. This resulted in new registered capital of Baht 1,545,458,883. The Meeting also approved increase in registered capital by way of a general mandate in the amount of Baht 154,545,888 from Baht 1,545,458,883, resulting in new registered capital of Baht 1,700,004,771for flexibility in raising capital for the business. However, to date, the Company has not increased capital through said general mandate.

Bangkok Dusit Medical Services Public Company Limited made a tender offer for all outstanding shares of Prasit Pattana Public Company Limited ("PYT") in order to delist shares of PYT from the Stock Exchange of Thailand with the Office of the Securities and Exchange Commission. After the tender offer, Prasit Pattana Public Company Limited delisted shares from the Stock Exchange of Thailand on 4th May 2012 and the Company now holds 98.32% of Prasit Pattana Public Company Limited.

The Company established a new 100% owned subsidiary under Bangkok Hospital Chiangmai Company Limited to construct a 200-bed hospital in Muang District, Chiangmai Province with registered capital of Baht 1,000 million and paid-up capital of Baht 250 million.

The Company established a new 100% owned subsidiary under Bangkok Hospital Udorn Company Limited to operate a 120-bed private hospital on Thongyai Road in Muang District, Udornthani Province with registered and paid-up capital of Baht 500 million. The subsidiary bought the business from Udorn Panyavej Hospital and officially commenced business as Bangkok Hospital Udorn on 12th December 2012, making it the 29th hospital in the Bangkok Hospital Group.

The Bangkok Hospital network is visionary in introducing technological innovation, namely ROBO DOCTOR or Remote Presence System from U.S.A., to increase efficiency of patient care. Patients have close and fast access to specialist physicians so that people in remote areas can be treated by standardized specialists. ROBO DOCTOR has been introduced in three hospitals, namely, Bangkok Hospital (Soi Soonvijai), Bangkok Hospital Phuket and Bangkok Hospital Pattaya to provide efficiency in patient referral and fast access to specialists. Patients and doctors are able to interact face-to-face and exchange information, which strengthens efficiency of care and confidence of the patients in accepting medical care.

Bangkok Hospital Medical Center and the College of Sports Science and Technology, Mahidol University received the FIFA Medical Centre of excellence Certificate from Jiri Dvorak, M.D., FIFA Chief Medical Officer. We are the first in Thailand and the ASEAN region and third in Asia (Japan, Qatar, Thailand and Saudi Arabia) to receive such honor. Currently, there are only 26 medical institutions around the world that have received such recognition. This clearly shows the continued dedication and role of Bangkok Hospital Medical Center in sports medicine. We have been responsible for taking care of the health of national football players and team members of the Thai premier league, in terms of medical care of injuries sustained by the athletes and rehabilitation as well as increasing physical fitness, preparation techniques before games and sports techniques for the greatest efficiency of the athletes, including nutrition and sports psychology.

Bangkok Hospital opened the Bangkok Academy of Sports and Exercise Medicine (BASEM) to strengthen our capabilities and raise the level of service with over Baht 70 million invested. BASEM was established to meet our objective of being the leader in health care, to meet the lifestyles of the new generation that like to exercise and play sports, as well as to provide care for sports-related injuries and analysis of problems in playing sports. The services include medical care of injuries sustained by the athletes and rehabilitation as well as increasing physical fitness, preparation techniques before games and sports techniques for the greatest efficiency of the athletes, including nutrition and sports psychology. Services in sports medicine will support Thailand's desire to be the medical hub and lead Bangkok Hospital to become the top sports medicine institute in ASEAN.

Bangkok Premier Life Insurance Broker, a subsidiary, which has expertise in health insurance within the Bangkok Hospital network, has joined hands with Muang Thai Life Assurance Company Limited to raise standard of living and health care by introducing an innovative life insurance product, health insurance and open up various channels of service. The cooperation has brought about newly developed health insurance policies that meet the needs of the consumers to access quality medical care while saving costs when in need.

The Phyathai Hospital Group and the Bangkok Hospital Group joined forces to open the Phyathai 3 Heart Center by Bangkok Heart Hospital with a budget of over Baht 100 million to expand client base in Thonburi area. Reiterating the Group's leadership in heart hospitals that meet international standards and the use of Off-Pump CABG. Moreover, the heart hospital provides complete service in health care and heart disease with state-of the-art technology and a team of specialists in all fields of heart disease to meet the international standards (JCI) and provide heart patients in the Thonburi area with the same level of service as received at Bangkok Heart Hospital. The Hospital provides complete diagnosis and treatment of heart and coronary disease from initial diagnosis, examination using special equipment, care and prevention of heart disease, surgery and after surgery recovery, as well as rehabilitation of the heart using internationally recognized modern medical equipment and technology.

The Bangkok Hospital Group joined forces with the Paolo Memorial Hospital Group to develop medical technology and medical services by opening the "Cancer Center" Paolo Memorial Hospital by Wattanosoth Hospital to meet the needs and lifestyles of patients as much as possible. The Center provides complete services in the prevention and treatment of cancer from detection of first stages of cancer, planning, treatment once detected to radiology to stop the spreading of cancer cells by a team of specialist doctors.

The Bangkok Spine Academy, Bangkok Hospital announced the success of a new surgical technique developed in Thailand to treat back pain through Direct Lateral Interbody Fusion (DLIF). The surgery treats back and leg pain caused by the spine pressing on the nerves or scoliosis. The distinctive points of this surgery are that it does not destroy the back muscles, less blood loss, small scar, and fast recovery. This technique uses Intraoperative Neuromonitoring sent through a 1-inch tube to monitor the nerves and spine. Then a replacement intervertebral disc is inserted making the spine stronger, enabling it to carry more body weight and lessening back pain. Moreover, the technique can effectively treat Spondylolisthesis or Scoliosis in elderly patients without having to make incisions along the back muscles, which may help lessen chronic back pain, median nerve entrapment, loose screws or loss of back muscle that occur after conventional surgery.

Bhumibol Adulyadej Hospital, Wattanosoth Hospital and Paolo Memorial Hospital Nawamin, being three public and private hospitals, joined together to organize the memorandum of understanding signing ceremony entitled "Out-Patient Referral for Radiology Treatment" for cancer patients using state-if-the-art medical technology to increase potential of radiology treatment for cancer patients of every group.

• The Company registered the long term land leasehold on Yaowarat Road with area of 1-0-99 rai including a 12,000 sq. m. building with the Best Fortune Property and Loan Fund for a period of 30 years. This was for the renovation of the land and building into a new private hospital under the name "Bangkok Hospital Chinatown". The hospital will provide selected tertiary care services and Advanced Emergency and Intermediate Care, and is expected to start operating in 2014.

• The Company has set up a new 100% owned subsidiary named, Bangkok Hospital Khon Khaen Company Limited with a registered and paid-up capital of Baht 600 million. The Company bought the Vechprasit Hospital building in Muang District, Khon Khaen Province and is renovating the building in order to open a new hospital under the name, Bangkok Hospital Khon Khaen. The new hospital is expected to open within 2014.

• The 2013 Annual General Meeting of the Shareholders on 18th April 2013 resolved to approve to extend the allocation of newly issued shares n under the General Mandate of no more than 154,545,888 shares at par value of Baht 1. The new shares are to be issued by the next Annual General Meeting of the Shareholders or within the date at which the law requires the next annual general meeting of the shareholders to be held , whichever comes first.

• The 2013 Annual General Meeting of the Shareholders on 18th April 2013 resolved to approve the purchase of shares of The Medic Pharma Company Limited from the existing shareholders. The Medic Pharma Company Limited was originally an associated company in which the company held 49% ownership. After the company purchased additional shares, the company's shareholding in the Medic Pharma Company Limited increased from 1,050,000 shares or 49% to 1,862,000 shares or 86.89% of the registered and paid-up capital.

• The Royal Bangkok Healthcare Company Limited (RBH), a 100% owned subsidiary, purchased shares of Krungthon Hospital (KDH) from some of the existing shareholders equal to 24.94% of the outstanding shares at Baht 55 per share. When combined with the existing KDH shares already held by the Company equal to 3,002,029 shares or 20%, RBH had to make a tender offer for all shares of KDH at the same price. After the tender offer, RBH held a total of 3,750,859 shares of KDH or 25.01%. This resulted in the ownership of 45.02% of KDH by the Bangkok Hospital Group. Consequently, Krungthon Hospital Public Company Limited registered its name change to "Thonburi Medical Center Public Company Limited" (Trading Name: KDH) and changed the name of the hospital to Samitivej Hospital Thonburi, making it the 30th hospital in the Bangkok Hospital Network.

• Later, at the KDH Extraordinary Shareholders' Meeting 1/2013 on 31st October 2013, the meeting approved the increase in registered capital of another Baht 75 million, resulting in registered capital increasing from Baht 150 million to Baht 225 million. The rights offering of 7.5 million shares at Baht 80 per share at 2:1, existing shares to new shares, garnered interest for only 4.384 million shares. While the Bangkok Hospital Group exercised its entire right to the new shares resulting in the increase of the Group's holding to 55.3% of the registered and paid-up capital after the rights offering (Baht 193.84 million).

• The Company set up a new wholly owned subsidiary named Bangkok Hospital Phitsanulok Company Limited with a registered and paid-up capital of Baht 600 million. On 1st October 2013, Phitsanulok Hospital purchased and took over the business of Rattanavej Hospital Company Limited, a private hospital in Muang District, Phitsanulok Province. The takeover was priced at Baht 576 million and the hospital reopened under the name "Bangkok Hospital Phitsanulok", making it the 31st hospital in the Bangkok Hospital Network. In addition, the company issued a rights offering under the general mandate for 3,636,771 shares to the existing shareholders of Rattanavej Hospital Company Limited through a private placement at Baht 127.22 per share totaling Baht 463 million. This increased the registered and paid-up capital from Baht 1,545,458,883 to Baht 1,549,095,654.

• The Company set up a new wholly owned subsidiary named Samitivej Chonburi Company Limited with a registered capital of Baht 600 million to operate a private hospital under the name "Samitivej Hospital Chonburi" in Muang District, Chonburi Province.

• The Company set up a new wholly owned subsidiary named Bangkok Hospital Surat Company Limited with a registered capital of Baht 300 million to operate a private hospital under the name "Bangkok Hospital Surat" in Muang District, Surat Thani Province.

• Bangkok Hospital Phuket Company Limited, a subsidiary in which the Company holds 99.69%, invested in the construction of a second hospital under the name "Deebuk Hospital" with total investment of approximately Baht 627 million and is expected to open within 2014.

• The Company has set up two holding companies in Singapore. The first holding company is BDMS Inter Pte. Ltd. with a registered capital of USD 40,000 and was set up for the Groups overseas investments. The second holding company is N Health Asia Pte. Ltd. with a registered capital of USD 40,000 and was set up for investments of the Group in offshore labs.
he investment in hospitals in the Lao People's Democratic Republic as well as investments in medical laboratories and equipment in the ASEAN region. The subsidiaries were set up through the holding company in Singapore and are as follows:
1. A subsidiary in the Lao People's Democratic Republic to invest in the construction of a hospital in Luang Prabang with a registered capital of about Baht 10 million and 100% owned by BDMS Inter Pte. Ltd. (Singapore).
2. N Health Myanmar Co., Ltd. with registered capital of USD 500,000 and 60% owned by N Health Asia Pte. Ltd. (Singapore).
3. N Health Laos Co., Ltd. with registered capital of USD 200,000 and 70% owned by with N Health Asia Pte. Ltd. (Singapore).
4. N Health Cambodia Co., Ltd. with registered capital of USD 320,000 and 100% owned by with N Health Asia Pte. Ltd. (Singapore).

  • The 2014 Shareholders’ Annual General Meeting held on 18th April 2014 approved the change in the par value of the Company’s common shares by reducing the par value from Baht 1 per share to Baht 0.10 per share, resulting in the increase of the number of the Company’s ordinary shares from 1,700,004,771 shares to 17,000,047,710 shares. However, the shareholding ratio of existing shareholders will not be affected by the change in the par value above and the registered capital as well as the paid-up capital of the Company will remain unchanged. The change in par value of the Company’s common shares came into effect on 25th April 2014.
  • The Extraordinary General Meeting of Shareholders of Bangkok Dusit Medical Services Public Company Limited No. 1/2014 held on 5th August 2014 approved the issuance and offering of unsecured and unsubordinated convertible bonds in an amount not exceeding Baht 10,000 million or an equivalent amount in other currencies. The bonds may be converted into ordinary shares of the Company during the term of the bond.

    On 18th September 2014, the Company offered the convertible bonds in the amount of Baht 10,000 million entirely to foreign investors. The convertible bonds are zero-coupon and may be redeemed in 2019. Subsequently, the Company listed the convertible bonds on the Singapore Exchange Securities Trading Limited on 19th September 2014 (details of the convertible bonds are shown on page 50)

  • The Extraordinary General Meeting of Shareholders of Bangkok Dusit Medical Services Public Company Limited No. 1/2014 held on 5th August 2014 approved the increase in the registered capital of the Company in the amount of Baht 100,691,217.40 from the existing registered capital of Baht 1,549,095,654 to Baht 1,649,786,871.40 by issuing 1,006,912,174 new ordinary shares at par value of Baht 0.10 per share, divided as follows:
    1. newly issued ordinary shares to support the conversion of the convertible bonds in the amount not exceeding 542,183,478 shares with par value of baht 0.10 per share (equal to 3.5% of the Company’s paid-up capital) and;
    2. newly issued ordinary shares under the general mandate in the amount not exceeding 464,728,696 shares with no more than 232,364,348 newly issued shares representing 1.5% of the Company’s paid-up capital to be allocated for offering to the public and no more than 232,364,348 newly issued shares representing 1.5% of the Company’s paid-up capital to be allocated for offering on a private placement basis.
      Either or both methods of allocation in aggregate shall not exceed 1.5% of the Company’s paid-up capital as at the date on which the Board of Directors resolved to approve the capital increase or totaling not exceeding 232,364,348 shares.

BDMS hospital network expansion and investment in healthcare related companies

  • On 31st January 2014, HRH Princess Maha Chakri Sirindhorn presided over the opening ceremony of Bangkok Hospital Chinatown, which began operating on 12th November 2014. The Hospital, a 59 bed private hospital, is located on Yaowaraj Road.
  • Bangkok Hospital Chiangmai Company Limited, a subsidiary in which the company holds 100%, officially opened the Bangkok Hospital Chiang Mai on 11th July 2014. Bangkok Hospital Chiangmai is a 185 bed private hospital located in Muang Chiangmai District, Chiangmai Province.
  • The Company established a new subsidiary of the Company under the name Bangkok Hospital Sanamchan Company Limited with a registered capital of Baht 3,655 million, divided into 365,500,000 ordinary shares with a par value of Baht 10 per share, approximately 99.99 per cent of which is held by the Company, in order to acquire and receive the transfer of the entire business of Sanamchan Hospital Company Limited ("Sanamchan”) which is a company operating a private hospital in Nakorn Pathom Province under the name "Sanamchan Hospital”. The transfer was completed on 15th August 2014 and the businesses transferred included Sanamchan Hospital, Muang Petch-Thonburi Hospital, as well as 44.5% equity interest in Thepakorn Hospital Company Limited and 25% equity interest in G. Wasupol Company Limited which currently operates Muang Ratch Hospital.
  • The Company established a subsidiary under the name "Bangkok Phuket International Hospital Company Limited” with a registered capital of Baht 3,610,000,000 divided into 361,000,000 ordinary shares with par value of Baht 10 per share, in which the Company holds 100%, to acquire and receive the entire business transfer of Phuket International Hospital Company Limited, which operates a private hospital under the name "Siriroj Hospital”, a 151 bed hospital in Phuket Province.
  • Bangkok Hospital Khon Kaen Company Limited, a subsidiary in which the company holds 100%, officially opened the Bangkok Hospital Khon Kaen on 10th November 2014. Bangkok Hospital Khon Kaen is a 140 bed private hospital located in Muang Khon Kaen District, Khon Kaen Province.
  • Phnom Penh Medical Services Company Limited, a subsidiary in which the company holds 100%, officially opened the Royal Hospital, Phnom Penh on 18th November 2014. Royal Hospital is a 100 bed private hospital located in Phnom Penh, Cambodia.
  • The Company has established the Bangkok Save Drug Company Limited with registered capital of Baht 450 million, divided into 45,000,000 common shares with a par value of Baht 10 per share, approximately 99.99% of which is held by the Company, in order to acquire all shares of Save Drug Center Company Limited, which is engaged in sale of medicine, supplementary food, and medical supplies and equipments businesses under the brand "Save Drug” through 107 stores and branches nationwide.

Medical Advancement and Development

  • Bangkok Hospital has upgraded its minimally invasive surgery technology with the introduction of the "Advanced 3D Laparoscopic Surgery”, which improves the accuracy and precision while providing natural 3D vision and depth perception while performing laparoscopic procedures. The procedure thus offers less scarring, less pain, and faster recovery. The technology is now being used at three major centers, including the Bangkok Surgery Clinic, Bangkok Women’s Health Center and Bangkok Urological Center and has expanded to treatment of cancer such as colon cancer, prostate cancer and gastric cancer.
  • Paolo Memorial Hospital Nawamin, under management of Thai Medical Center Public Company Limited, has changed its name to "Phyathai Hospital Nawamin”. In addition, the hospital has improved the quality and standards of its medical services with physicians specializing in various areas and state-if-the-art technology enabling the hospital to provide care for more complex ailments which meet the standards of the Phyathai Hospital Group. This improvement has resulted in quality medical services for the greatest benefit to the patients.
  • Bangkok Hospital awarded prizes to the Bangkok Emergency Services (BES) and OPD Patient Flow Project in the category of Core Process Improvement Project to applaud departments that aimed to improve internal processes, lessen redundancy, lower cost, increase efficiency, increase speed and lessen procedural mistakes within the organization.
  • Bangkok Heart Hospital opened the Hybrid OR, which can rotate 360 degrees freely while taking
    "Flex Move Heart Navigator” and "Software Heart Navigator” x-rays and can make an image of the heart in great detail. It has the capability to perform a Transcatheter Aortic Valve Implantation, Valvular Repair or Stenting using a Fluoroscopy. The highlight of the Hybrid OR is that it combines the Catheterization Unit and the Cardiothoracic Surgeries into one room. In the case that there are complications, the surgeons can operate immediately without having to move the patient.
  • Bangkok Hospital opened the "Brain Power, Fit Brain, Firm Life Center” "Bangkok Hospital open"
    The Brain Power center” providing full service care for the brain with physicians from 5 clinics, namely, Stroke Clinic, Epilepsy Clinic, Memory Clinic, Headache Clinic, and Parkinson’s and Movement Disorder Clinic.
  • National Healthcare Systems Company Limited (N health), a subsidiary of Bangkok Hospital, and the National Science and Technology Development Agency (NSTDA), Ministry of Science and Technology signed a memorandum of understanding on research & product development and medical services support. The aim, through the experience and expertise of N health, is to stimulate product development, material development and efficient medical care, as well as push for real practice in leading hospitals both in Thailand and offshore in order to decrease imports and turn Thailand into a medical hub in anticipation of the growth in the ASEAN region.
  • The Bangkok Health Research Center, Bangkok Hospital Group has been certified as a AO Clinical Study Site (AOCSC) by the AO Foundation. This certi􀅳es that the Center’s clinical research, training of clinical research personnel and important role in controlling the quality of clinical research in the field of Orthopaedic Surgeryand the treatment of bones and joints meet international standards.
  • HRH Princess Maha Chakri Sirindhorn presided over the opening of the 2014 annual academic conference organized by Bangkok Dusit Medical Services Public Company Limited entitled "Get Healthy Get Ready for ASEAN Community”, which was comprised of 6 hospital groups, namely, Bangkok Hospital, Samitivej Hospital, BNH Hospital, Phyathai Hospital, Paolo Memorial Hospital and Royal Hospital in Cambodia. HRH graciously supported the cooperation in providing healthcare of the Thai people of all genders and ages, the development of medical academics and the integration of Thai public health as well as publicizing Thailand’s potential in terms of medical care and public health to the ASEAN Community and the international medical center at the World Heart Day on 26th September 2014.
  • BDMS organized a press conference to announce a new upgrade to the Group’s medical services with the launch of "B-eXchange”, a database that connects medical records in its hospital network into one centralised system. The system is being implemented within the Bangkok Hospital, Samitivej Hospital, BNH Hospital, Phyathai Hospital and Paolo Memorial Hospital to increase the quality of medical services and decrease treatment errors, thus creating a foundation to becoming the medical hub of the ASEAN region.

Medical Cooperation

  1. Sano Hospital
    On 9th July 2014, Samitivej Public Company Limited, the Company subsidiary, signed an agreement with Sano Hospital, Japan for cooperation in studying and developing projects on gastrointestinal tract disease, as well as patient referrals, as appropriate to the illness, between the two hospitals.
  2. MD Anderson
    On 1st August 2014, Bangkok Dusit Medical Services Public Company Limited, Faculty of Medicine Siriraj Hospital and MD Anderson (University of Texas: MD Anderson Cancer Center – MDACC) signed an agreement on cooperation on the Global Academic Program (GAP), an academic and research project, as well as the MD Anderson Cancer Network Associate Project, a project on treatment of the disease. Later, on 16th November 2014, Wattanosoth Hospital and the Faculty of Medicine Siriraj Hospital became "Sister Institutes” of MDACC under GAP. The Company continues to achieve cooperation in treatment of cancer in the future.
  3. Stanford University
    On 6th August 2014, the Bangkok Orthopaedic Center, Bangkok Hospital and the Department of Orthopaedic Surgery, Standford University signed a Memorandum of Understanding to exchange knowledge and skills in the field of orthopaedics with a focus on excellence in the treatment of the musculoskeletal system. The cooperation also seeks to develop knowledge through research in orthopaedic surgery as well as improve the efficiency in the treatment of patients with such ailments. The signing of the agreement will lead to cooperation in studies, research and medical conferences to develop the potential of medical personnel.
  4. Oregon Health & Science University (OHSU)
    On 1st October 2014, Bangkok Dusit Medical Services Public Company Limited together with the Oregon Health & Science University (OHSU) established the BDMS-OHSU International Health Alliance to become an international medical center and elevate to a medical excellence center in all areas, especially in occupational health and pediatrics, in the Asia Paci􀅳c region.
  5. Heavy Ion Therapy
    On 9th October 2014, Wattanosoth Hospital, a hospital specializing in cancer, signed an agreement to collaborate with Universal Strategy Institute Limited Liability Company, Japan on the establishment of an irradiation center, which will use the "Heavy Ion Therapy” technology, as part of the plan to become the center for cancer treatment in the Asia Paci􀅳c region. The technology is state-of-the-art and effective in the treatment of cancer with shorter treatment time and fewer side effects. The treatment can be used with patients who are not suited to the conventional irradiation or for those who did not see results with the conventional irradiation. The advantage of this treatment is that it is highly accurate. The beams can destroy deep cancer cells with accuracy with the suitable amount of ions as the beam will relieve most of the energy on the position so that the amount of ions that passes through the body will have as little effect on the normal cells as possible.
  6. Nagoya University
    Bangkok Dusit Medical Services Public Company Limited together with Nagoya University, Japan signed an agreement on two significant items, (1) cooperation in studies through medical personnel exchanges for training in all fields of medicine and (2) referrals of patients between the University and the Hospital in the case that a patient should be travelling to Thailand (and neighboring countries) or to Nagoya (and nearby places).

Accreditation and Special Recognition

  • As at the end of 2014, the Company’s group of private hospitals includes 19 hospitals that have received national recognition by the Hospital Accreditation Thailand (HA). The Group also has 12 hospitals and 1 clinic that have received international recognition by the Joint Commission International (JCI), namely, Bangkok Hospital Medical Center (comprised of 3 hospitals which are Bangkok Hospital, Bangkok Heart Hospital and Wattanosoth Hospital), Bangkok Hospital Pattaya, Bangkok Hosptial Phuket, Bangkok Hospital Samui, Bangkok Hospital Hua Hin, Samitivej Hospital Sukhumvit, Samitivej Hospital Srinakarin, Samitivej Hospital Sriracha, BNH Hospital and International Clinic Koh Chang.
  • BDMS received the "Southeast Asia Top Companies for Leaders Special recognition 2014” presented by AON Hewitt. The Company was selected from leading organizations around the world in terms of connectivity and consistency of leadership practices and financial results.

 

 

Expansion of BDMS network

  • The Company changed the ticker symbol from "BGH” to "BDMS”.
  • Bangkok Hospital Rayong Company Limited, a subsidiary in which the Company holds 100%, officially opened the Sri-Rayong Hospital on 5th January 2015. Sri-Rayong Hospital is a private hospital with 195 beds located in Cheung Nern Sub-District, Muang District, Rayong Province, which aims to provide service to patients entitled to social security benefits in Rayong Province.
  • Royal Bangkok Healthcare Company Limited ("RBH”), which is a 100% owned subsidiary, purchased shares of General Hospital Products Public Company Limited ("GHP”), a manufacturer of intravenous solutions namely, saline, glucose and other medical supplies. The Company holds shares of GHP through RBH and Medic Pharma Company Limited equal to 44.67% of the registered capital of General Hospital Products Public Company Limited.
  • Samitivej Chonburi Company Limited, a subsidiary in which the Company holds 100%, officially opened Samitivej Chonburi Hospital on 1st June 2015. Samitivej Chonburi Hospital is a medium sized general hospital with 57 beds located on Sukhumvit Road, Baan Suan Sub-District, Muang District, Chonburi Province.
  • Bangkok Phuket Hospital Company Limited, a 100% owned subsidiary, officially opened Dibuk Hospital on 9th July 2015. Dibuk Hospital is a 32-bed private hospital located on Chao Fah Tawantok Road, Wichit Sub-District, Muang District, Phuket Province, and aims to provide primary care, as well as services to patients on life insurance and car insurance, at a reasonable price.
  • The Company established a 100% owned new subsidiary named Bangkok Hospital Chiang Rai Company Limited, aiming to invest in a private hospital in Chiang Rai Province, with a registered capital of Baht 100 million.
  • Bangkok Hospital Muangraj Company Limited, a 100% owned subsidiary, acquired and accepted the transfer of the entire business of G. Wasupol Company Limited, which operated a private hospital named Muangraj Hospital in Ratchaburi province. Bangkok Hospital Muangraj Company Limited paid a total of Baht 1,427,030,155.50 on 1st September 2015 and accepted all the liabilities of G. Wasupol Company Limited, which would not exceed Baht 47 million.

Development in Medication

  • HRH Princess Maha Chakri Sirindhorn presided over the opening of the 2015 annual academic conference "Global Alliance to Excellent Health Care” organized by Bangkok Dusit Medical Services Public Company Limited, which includes Bangkok Hospital Group, Samitivej Hospital, BNH Hospital, Phayathai Hospital, Paolo Hospital and Royal Hospital, held at the Intercontinental Hotel.
  • Samitivej Hospital opened the Critical Care Complex, a state of the art medical center providing complete medical care, which includes 8 new operating rooms, 5 labour rooms, a neonatal intensive care unit and 16 new ICU rooms. All these rooms have been designed to provide the best working environment for surgeons, moreover, the eight new state-of-the-art surgical suites are all fully equipped with the latest surgical technology to increase patients’ safety and well being.

Awards Received

  • The Company received the "Thailand’s Top Corporate Brand 2015” award in the category of medicine, from the Faculty of Commerce and Accountancy, Chulalongkorn University, with an organizational brand worth Baht 178,000.29 million, ranking fifth. On this occasion, Mr.Prasert Prasarttong-Osoth, M.D., Group Chief Executive Officer and President, received the award from Professor Pirom Kamolratanakul, M.D., President of Chulalongkorn University.
  • Mr.Prasert Prasarttong-Osoth, M.D., Group Chief Executive Officer and President, Bangkok Dusit Medical Services Public Company Limited received the "2014 Thailand Outstanding Hospital Administrator of the Year” award from Privy Councillor Kasem Watanachai, M.D. organized by the Thailand Hospital Administrator Association. The Association selects successful hospital administrators with well recognized achievements and are good examples for the public health organizations at the 2015 annual academic conference held at the Bamrasnaradura Infectious Diseases Institute, Ministry of Public Health.
  • The Stock Exchange of Thailand together with Money & Banking Magazine awarded the Company the "2015 Outstanding Investor Relations Award” for listed companies with market capitalization of over Baht 100,000 million.
  • Bangkok Hospital received the Advanced HA Certificate for process in improving hospital quality in accordance with the Hospital and Healthcare Organization Standards, the 60th Anniversary of His Majesty the King’s Accession to the Throne Edition, from the Ministry of Public Health at the opening ceremony of the 16th HA National Forum. A total of 3 hospitals have received this level of accreditation, namely, Siriraj Hospital, Bhumibol Hospital and Bangkok Hospital.
  • Bangkok Hospital received the TQM-Best Practices in Thailand award for work on Information Management in Hospitals, which utilizes information management to support the hospital’s business in Critical Care Information System (CCIS) to care for diabetes patients (EMR system).
  • Bangkok Chantaburi Hospital received the Thailand Energy Awards 2015 for energy conservation in the category of controlled buildings, from the Ministry of Energy.
  • Samitivej Public Company Limited, a subsidiary, received the following awards:
    • Thailand Top Company Awards 2015 for the third consecutive year in the category of Best Medical Healthcare Organization from the University of the Thai Chamber of Commerce together with Business Magazine. It is a prestigious award given to companies with outstanding performance in medicine and healthcare through corporate governance.
    • HRH Crown Princess Maha Chakri Sirindhorn's Thailand Corporate Excellence Awards 2015. The Company received the TMA-SASIN Management Excellence Award in the category of medium sized organization with annual revenue under Baht 10,000 million from the Thailand Management Association (TMA) in collaboration with the Sasin Graduate Institute of Business Administratoin (Sasin) of Chulalongkorn University. The award honors companies for their business excellence.
  • A.N.B. Laboratories Company Limited and Medic Pharma Company Limited, both subsidiaries of the Company, received the Quality Award from the Food and Drug Administration for the second consecutive year. This award, under the theme "Quality, Safety, Social Responsibility”, is given as recognition of the subsidiaries’ achievement as a morally and ethically relevant workplace in manufacturing healthcare products, which meet safety and quality standards.

Medical Cooperation

  1. Sano Hospital
    Samitivej Public Company Limited, a company subsidiary, signed an agreement with Sano Hospital, Japan for cooperation in studying and developing projects on gastrointestinal tract disease, as well as patient referrals, as appropriate to the illness, between the two hospitals.
  2. MD Anderson
    Bangkok Dusit Medical Services Public Company Limited together with the Faculty of Medicine Siriraj Hospital collaborated to become a Sister Institution of MD Anderson Cancer Center (MDACC) of the University of Texas, U.S.A. under the Global Academic Program (GAP). This is the first time for collaboration among 3 institutions from public and private organizations in Thailand and the U.S.A., to support basic research and developments in safe and efficient treatment, as well as the exchange of knowledge and case studies across the regions, to provide happiness, quality of life, including the prevention and cure of cancer.
  3. Stanford
    The Bangkok Orthopaedic Center, Bangkok Hospital and the Department of Orthopaedic Surgery, Standford University signed a Memorandum of Understanding to exchange knowledge and skills in the field of orthopaedics with a focus on excellence in the treatment of the musculoskeletal system. The cooperation also seeks to develop knowledge through research in orthopaedic surgery as well as improve the efficiency in the treatment of patients with such ailments. The signing of the agreement will lead to cooperation in studies, research and medical conferences to develop the potential of medical personnel.
  4. OHSU
    BDMS with the Oregon Health & Science University (OHSU) established the BDMS-OHSU International Health Alliance to become an international medical center and elevate to a medical excellence center in all areas, especially in occupational health and pediatrics, in the Asia Pacific region.
  5. Heavy Ion Therapy
    Wattanosoth Hospital, a hospital specializing in cancer, signed an agreement to collaborate with Universal Strategy Institute Limited Liability Company, Japan on the establishment of an irradiation center, which will use the "Heavy Ion Therapy” technology, as part of the plan to become the center for cancer treatment in the Asia Pacific region. The technology is state-of-the-art and effective in the treatment of cancer with shorter treatment time and fewer side effects. The treatment can be used with patients who are not suited to the conventional irradiation or for those who did not see results with the conventional irradiation. The advantage of this treatment is that it is highly accurate. The beams can destroy deep cancer cells with accuracy with the suitable amount of ions as the beam will relieve most of the energy on the position so that the amount of ions that passes through the body will have as little effect on the normal cells as possible.
  6. Nagoya
    Bangkok Dusit Medical Services Public Company Limited together with Nagoya University, Japan signed an agreement on two significant items, (1) cooperation in studies through medical personnel exchanges for training in all fields of medicine and (2) referrals of patients between the University and the Hospital in the case that a patient should be travelling to Thailand (and neighboring countries) or to Nagoya (and nearby places). This is a great opportunity to enhance the potential of Thai medical personnel in order to be able to provide more internationally standardized services. A representative from the Japanese Embassy in Thailand was invited to witness the signing ceremony.
  7. Collaborated with one of the leading neurosurgeons
    BDMS has collaborated with Dr. Kieth L. Black, one of the leading neurosurgeons in the world and currently holds the position of Director of the Maxine Dunitz Neurosurgical Institute at Cedars-Sinai Medical Center in Los Angeles, California. This collaboration has focused on researching and developing capabilities in treating diseases of the brain and nervous system, thus, enabling BDMS to become one of the most up-to-date medical centers in diseases of the brain and nervous system (neuroscience) in the Asia Pacific Region.
  8. Straumann
    Bangkok Hospital Dental Center has worked in collaboration with Straumann, a world-renown expert in implant, restorative and regenerative dentistry, in order to increase our efficiency in the dentistry implant and oral hygiene care. We have thus, been appointed as Straumann Partner Center Thailand.
  9. Doernbecher Children’s Hospital
    Samitivej Public Company Limited, a subsidiary, signed an alliance agreement with Doernbecher Children’s Hospital located in Oregon, U.S.A., a well-known children’s hospital awarded the highest rating for quality and safety in children’s health care in 2014 from the University Health System Consortium of hospitals for pediatric quality. Samitivej also opened the Samitivej International Children’s Hospital, both at Sukhumvit and Srinakarin, and has developed a Center of Excellence. Samitivej International Children’s Hospital has supported the national policy and direction of Thailand to become the medical hub of the Asia-Pacific Region.

Quality of Service

As at the end of 2014, the Company’s group of private hospitals includes 19 hospitals that have received national recognition by the As of the end of 2015, the Company’s network of private hospitals had received accreditation at various levels. A total of 22 hospitals were certified by Hospital Accreditation (HA) and 12 organizations (11 hospitals and 1 clinic) were certified by the Joint Commission International (JCI). Furthermore, Bangkok Hospital received Advanced HA, making us one of only three hospitals in Thailand to receive such an accreditation, the other two hospitals being Siriraj Hospital and Bhumibol Hospital.

 

 

Expansion of BDMS network

  • Royal Bangkok Healthcare Company Limited, a subsidiary in which the Company holds 100%, acquired the remaining shares of Bangkok Helicopter Services Company Limited (BHS) from South East Air Company Limited, making BDMS the owner of 100% of BHS. BHS has increased its registered capital from Baht 100 million to Baht 300 million. The increase capital has been used to facilitate two Sky ICU units, Helicopter BHS1 (model EC145) and Helicopter BHS2 (model H145). The two helicopters are ready to operate 24 hours and can provide emergency care, as if the patient were in intensive care, from departure to the hospital.
  • Bangkok Helicopter Services Company Limited (BHS), a subsidiary, leased an airplane model ATR72 from Bangkok Airways Company Limited for three years. The airplane is to be used to care for and transfer patients of the BDMS hospital network. It more efficiently facilitates rapid medical services and transfer of patients and their family, physicians and nurses by air domestically and internationally.
  • The Company established a new wholly owned subsidiary, BDMS Asset Management Company Limited, to manage non-hospital related assets with a registered capital of Baht 10 million.
  • The Company established a new wholly owned subsidiary, BDMS Wellness Clinic Company Limited, to purchase the land where the Park Nai Lert Project was situated on No. 2 Wittaya Road, Lumpini Sub-District, Pathumwan District, Bangkok. The land has total area of approximately 15 rai and includes the Swissotel building and the Promenade building, with total value of Baht 10,800 million and capital expenditure for property development of approximately Baht 2,000 million. The land will be used to develop the BDMS Wellness Clinic, which seeks to provide integrated care for the well-being of our patrons, both physically and mentally, as well as enhance longevity.
  • Paolo Medic Company Limited (“Paolo”), a subsidiary in which the Company holds 99.99%, acquires and receives the transfer of the entire business of Mayo Polyclinic Company Limited (“MYPC”), a 162 bed private hospital operating under the name of Mayo Hospital situated on Phahonyothin Road, Chatuchak District, Bangkok. Paolo paid MYPC Baht 1,390 million and completed the transaction in January 2017. Paolo increased the registered capital from Baht 600 million to Baht 1,000 million in order to pay for the acquisition of MYPC
  • The Medic Pharma Company Limited, within the BDMS Group, opened a new medicine manufacturing plant on 15 rai land in the Sinsakhon Industrial Park, Samutsakhon Province. The new plant has comprehensive innovation and technology that meet international quality standards to support both domestic and foreign demand. Thus increasing the opportunity for Thais and Asians to access high quality modern medicine that is produced in a plant that meets international standards.

Honours and Awards

  • BDMS received “The Best Manage Company Award for Thailand 2016 – Large Capitalization” from Asia Money magazine. This award was based on the results of a poll conducted with investors and analysts from around the world. The award ceremony was held on 22 February 2017 at the Conrad Hotel in Hong Kong.
  • Medic Pharma Company Limited, a subsidiary, received the “FDA Quality Award” for the third consecutive year from the Food and Drug Administration. The award is presented to enterprises that have shown virtue and ethics in the production of quality goods under approved standards and safety. The motto of the award was “Quality, Safety, Socially Responsible”.
  • The Company received the “Thailand’s Top Corporate brand 2016” in the field of medicine for the second consecutive year, with brand value of Baht 192,677 million, from the Faculty of Commerce and Accounting, Chulalongkorn University. On this occasion, Ms. Poramaporn Prasarttong- Osoth M.D., CEO Group 1, received the award on behalf of the Company from Professor Bundhit Eua-arporn, Ph.D., President of Chulalongkorn University.
  • Bangkok Hospital received three awards from the Thailand Management Association (TMA) as part of the Thailand ICT Excellence Awards 2016. The awards were for Innovation Projects Excellence, Knowledge Management Projects Excellence and Core Process Improvement Projects Excellence. All three awards are for excellence in management of information technology and communications, and application of Thai software in efficient organizational development.

Medicine and Medical Care

  • Bangkok Hip & Knee Center, Bangkok Hospital, announced their success in developing a new technique to treat osteoarthritis of the hip with “Direct Anterior Approach Total Hip Replacement”. The technique requires an incision located at the front of the hip without the surgeon having to detach any of the muscles or tendons. It also reduces pain, has minimal scarring, allows for convenient movement, reduces complications, has faster post-operative recovery and reduces dislocation after surgery, thus, providing a better quality of life for the patient.
  • Wattanosoth Hospital announced the new PET/CT with flow motion. The scanner is able to precisely diagnose cancer faster, is smaller and can increase the opportunity of treating cancer in a timely manner. Wattanosoth Hospital acquired the two new model PET/CT scanners to better accommodate the increasing number of cancer patients.
  • Bangkok Hospital opened the “Bangkok Sleep & Epilepsy Center” providing a sleep lab to diagnose patients who experience symptoms during sleep such as snoring, sleep apnea, excessive sleepiness and narcolepsy. The Center also provides advice on innovation and technolog that can diagnose with precision.
  • HRH Princess Maha Chakri Sirindhorn presided over the opening of the 2016 annual academic conference “Excellent Healthcare Network Through Research and Innovation” organized by Bangkok Dusit Medical Services Public Company Limited, which includes Bangkok Hospital Group, Samitivej Hospital, BNH Hospital, Phayathai Hospital, Paolo Hospital, Royal Hospital and non-hospital businesses, held at the Intercontinental Hotel. Many renowned medical specialists in various fields from around the world, along with Thai experts shared their knowledge through seminars and training covering numerous fields including medicine, dentistry, pharmacy, nursing, research and medical innovation. The aim is to encourage collaboration to elevate the standards in research, medical academics, nursing, medical and public health services to the international level and to better the quality of healthcare in the future.
  • Bangkok Hospital introduced a new technique in diagnosing orthopedic problems with precision. The Hospital introduced the Biplane Imaging (EOS) machine, which allows for a life-size full-body image of your skeleton in 3D, in your natural standing position or global balance. Biplane Imaging (EOS) captures the whole skeletal system in a single scan. Frontal and lateral images are obtained simultaneously and presented as a 3D model, using from 6 to 9 times less radiation than x-rays. This allows physicians to evaluate and diagnose bones and structure with precision whether it be the neck bone, spine or ankle.
  • Phyathai Hospital 1 received accreditation as a “Comprehensive Stroke Center” from DNV-GL, an international accreditation from Europe and U.S.A. Presently, stroke is the number one critical disease that has taken the lives of Thais.
  • Phyathai Hospital 1 launched the “Mobile CT & Stroke Treatment Unit”, the first mobile unit of its kind in Asia, providing faster medical care to stroke patients than regular ambulances in order to provide comprehensive medical care for the best benefit of the patient.

Medical Cooperation

  1. Sano Hospital
    Samitivej Public Company Limited, a company subsidiary, signed an agreement with Sano Hospital, Japan for cooperation in studying and developing projects on gastrointestinal tract disease, as well as patient referrals, as appropriate to the illness, between the two hospitals.
  2. MD Anderson
    Bangkok Dusit Medical Services Public Company Limited together with the Faculty of Medicine Siriraj Hospital collaborated to become a Sister Institution of MD Anderson Cancer Center (MDACC) of the University of Texas, U.S.A. under the Global Academic Program (GAP). This is the first time for collaboration among 3 institutions from public and private organizations in Thailand and the U.S.A., to support basic research and developments in safe and efficient treatment, as well as the exchange of knowledge and case studies across the regions, to provide happiness, quality of life, including the prevention and cure of cancer.
  3. Stanford
    The Bangkok Orthopaedic Center, Bangkok Hospital and the Department of Orthopaedic Surgery, Standford University signed a Memorandum of Understanding to exchange knowledge and skills in the field of orthopaedics with a focus on excellence in the treatment of the musculoskeletal system. The cooperation also seeks to develop knowledge through research in orthopaedic surgery as well as improve the efficiency in the treatment of patients with such ailments. The signing of the agreement will lead to cooperation in studies, research and medical conferences to develop the potential of medical personnel.
  4. OHSU
    BDMS with the Oregon Health & Science University (OHSU) established the BDMS-OHSU International Health Alliance to become an international medical center and elevate to a medical excellence center in all areas, especially in occupational health and pediatrics, in the Asia Pacific region.
  5. Heavy Ion Therapy
    Wattanosoth Hospital, a hospital specializing in cancer, signed an agreement to collaborate with Universal Strategy Institute Limited Liability Company, Japan on the establishment of an irradiation center, which will use the "Heavy Ion Therapy” technology, as part of the plan to become the center for cancer treatment in the Asia Pacific region. The technology is state-of-the-art and effective in the treatment of cancer with shorter treatment time and fewer side effects. The treatment can be used with patients who are not suited to the conventional irradiation or for those who did not see results with the conventional irradiation. The advantage of this treatment is that it is highly accurate. The beams can destroy deep cancer cells with accuracy with the suitable amount of ions as the beam will relieve most of the energy on the position so that the amount of ions that passes through the body will have as little effect on the normal cells as possible.
  6. Nagoya
    Bangkok Dusit Medical Services Public Company Limited together with Nagoya University, Japan signed an agreement on two significant items, (1) cooperation in studies through medical personnel exchanges for training in all fields of medicine and (2) referrals of patients between the University and the Hospital in the case that a patient should be travelling to Thailand (and neighboring countries) or to Nagoya (and nearby places). This is a great opportunity to enhance the potential of Thai medical personnel in order to be able to provide more internationally standardized services. A representative from the Japanese Embassy in Thailand was invited to witness the signing ceremony.
  7. Collaborated with one of the leading neurosurgeons
    BDMS has collaborated with Dr. Kieth L. Black, one of the leading neurosurgeons in the world and currently holds the position of Director of the Maxine Dunitz Neurosurgical Institute at Cedars-Sinai Medical Center in Los Angeles, California. This collaboration has focused on researching and developing capabilities in treating diseases of the brain and nervous system, thus, enabling BDMS to become one of the most up-to-date medical centers in diseases of the brain and nervous system (neuroscience) in the Asia Pacific Region.
  8. Straumann
    Bangkok Hospital Dental Center has worked in collaboration with Straumann, a world-renown expert in implant, restorative and regenerative dentistry, in order to increase our efficiency in the dentistry implant and oral hygiene care. We have thus, been appointed as Straumann Partner Center Thailand.
  9. Doernbecher Children’s Hospital
    Samitivej Public Company Limited, a subsidiary, signed an alliance agreement with Doernbecher Children’s Hospital located in Oregon, U.S.A., a well-known children’s hospital awarded the highest rating for quality and safety in children’s health care in 2014 from the University Health System Consortium of hospitals for pediatric quality. Samitivej also opened the Samitivej International Children’s Hospital, both at Sukhumvit and Srinakarin, and has developed a Center of Excellence. Samitivej International Children’s Hospital has supported the national policy and direction of Thailand to become the medical hub of the Asia-Pacific Region.
  10. Missouri Orthopedic Institute, University of Missouri, U.S.A.
    Bangkok Dusit Medical Services Public Company Limited and the Missouri Orthopedic Institute signed an agreement to collaborate in the exchange of knowledge and skills in orthopedics between the Bangkok Orthopedic Center at Bangkok Hospital and the Missouri Orthopedic Institute at the University of Missouri, U.S.A., through various activities such as academic conferences to continuously improve our personnel as well as supporting research in orthopedics and other medical cooperation. This collaboration shall improve the efficiency of orthopedic patient care.
  11. Hannover Medical School, Germany
    Bangkok Dusit Medical Services Public Company Limited and the Hannover Medical School signed an agreement to collaborate in the exchange of knowledge and skills in orthopedics and trauma surgery between the Bangkok Orthopedic Center at Bangkok Hospital and the Department of Orthopedics and Trauma at Hannover Medical School, Germany. Through the agreement, we have organized medical seminars, as well as sent physicians and nurses to Hannover Medical School for short-term and long-term training in order to continuously develop the capabilities of our personnel and support research in orthopedics and trauma to improve efficiency of orthopedic and trauma patient care.
  12. Collaboration between Samitivej Children’s Hospital and Takatsuki Hospital Japan
    Samitivej Children’s Hospital, a subsidiary, and Takatsuki Hospital, Japan signed and alliance agreement in pediatrics and neonatal intensive care unit (NICU) to develop medical personnel and exchange experiences in order to further the potential of Samitivej, better the quality of life of child patients and provide comprehensive medical care that meet international standards.
  13. N Health Pathology Company Limited together with the Royal College of Pathologists of Thailand organized the Interhospital Renal Clinicopathological Conference
    N Health Pathology Company Limited together with the Royal College of Pathologists of Thailand organized the Interhospital Renal Clinicopathological Conference 1/2016 giving the opportunity to over 50 kidney and pathology specialists as well as resident physicians from various medical schools and hospitals in Thailand to share interesting case studies to enhance diagnostics and treatment. The kidney academic conference shall be held every two months,

Quality of Service

At the end of 2016, the Group had a total of 31 hospitals within the network that had received accreditation from Hospital Accreditation Thailand (HA). In addition, 14 hospitals had received accreditation from Joint Commission International (JCI). Bangkok Hospital also received Advanced HA Accreditation. The hospitals are listed below: